Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn about the credit cards that provide the best cash back and points potential. Unlock the rewards that suit your spending habits.
28,655 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
The Bank of England unveiled a tokenization agenda and a framework for systemic sterling stablecoins, with a two-stag...
As investors await Hyperfine's HYPR 2025 earnings, this guide breaks down what the numbers could show, how to read th...
Binance withdraws its Greece bid and says it has one week to secure an EU license. The company reiterates that binanc...
A seasoned political strategist warns that without a concrete, consumer-focused economic message, Democrats could str...
New Rochelle's zoning reform has sparked a housing surge, signaling a blueprint for faster development and safer lend...
Blue Sage Solutions and Kinective announced a strategic partnership to streamline how community banks and credit unio...
A couple claiming Social Security at 62 invested the checks, but quarterly dividends pushed most of their benefits in...
Two lawsuits over Anywhere Real Estate’s homebuyer commissions collide in Illinois courts as plaintiffs seek to conso...
JPMorgan Chase CEO Jamie Dimon cautions that inflation could reappear if geopolitical shocks linger, rattling investo...
Federal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...